Bank Of America Corp Genfit S.A. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$3.53 - $4.39 $2,749 - $3,419	-779 Reduced 72.8%	291 $1,000
Q3 2022 Nov 14, 2022	BUY	$3.26 - $4.86 $3,488 - $5,200	1,070 New	1,070 $4,000
Q1 2022 May 16, 2022	SELL	$3.14 - $5.04 $405 - $650	-129 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$3.01 - $5.65 $388 - $728	129 New	129 $1,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.